Wellesley, Mass. (PRWEB) October 15, 2014
The Cure Alzheimer’s Fund today announced that one of its lead researchers, Dr. Rudy Tanzi, has led a team in the creation of human brain cells that can develop the defining characteristics of Alzheimer’s in a Petri dish, allowing unparalleled study of the disease. Dr. Tanzi’s groundbreaking research technique, which has been dubbed “Alzheimer’s in a Dish," represents a great leap forward in Alzheimer’s research.
Dr. Tanzi's research and his leadership of the Cure Alzheimer’s Fund will be featured at today's Cure Alzheimer’s Fund Fall Symposium in Boston.
“The symposium will celebrate a decade of accomplishments under the scientific leadership of Dr. Rudy Tanzi and a brilliant team of researchers, including a Scientific Advisory Board which includes two Nobel Prize winners,” said President and CEO of the Cure Alzheimer’s Fund Tim Armour. “We are grateful to the founding families, directors and more than 15,000 individuals and institutions that have supported groundbreaking research.”
The Cure Alzheimer’s Fund was founded with the venture capitalist mindset of financially backing scientific visionaries conducting research about Alzheimer’s disease considered too risky to qualify for traditional funding.
Under Dr. Tanzi’s leadership, a “Research Consortium” of world-class researchers carries out cutting-edge research within the parameters of a carefully developed research strategy known as the “The Roadmap.” Dr. Tanzi will deliver an outline of the Cure Alzheimer’s Fund method and the state of Alzheimer’s research in his keynote address at today’s symposium.
“Ten years ago, there was little hope of finding a cure for the disease due to a lack of understanding and funding for research,” added Jeff Morby, chairman and co-founder of Cure Alzheimer’s Fund. “Ten years later, the very limited knowledge of Alzheimer’s in 2004 has exploded into a nearly complete understanding of the basic causes of Alzheimer’s disease and the pathways to a cure."
"We now have one of the largest databases in the world of AD genes, and the database is providing countless insights into the disease and opportunities for therapies to prevent the disease – all of which we are pursuing," said Morby.
About Cure Alzheimer’s Fund:
Cure Alzheimer’s Fund takes a venture capital approach to medical research by finding the visionaries in the field, supporting them, focusing on the essentials by establishing a frugal culture and daring to be great. Our research objective is to support the scientists doing the most innovative work that will move knowledge of Alzheimer’s pathology most expeditiously to prevention and cure. Read more about the research being supported by the Cure Alzheimer’s Fund by clicking here.